awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38128723-406167A4-F42D-49EC-8958-7AD3C62AF8CE
Q38128723-406167A4-F42D-49EC-8958-7AD3C62AF8CE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38128723-406167A4-F42D-49EC-8958-7AD3C62AF8CE
The development of dasatinib as a treatment for chronic myeloid leukemia (CML): from initial studies to application in newly diagnosed patients.
P2860
Q38128723-406167A4-F42D-49EC-8958-7AD3C62AF8CE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38128723-406167A4-F42D-49EC-8958-7AD3C62AF8CE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
76e671189a8103494b0572666a849a6d6439a6bc
P2860
Differential effects of dosing regimen on the safety and efficacy of dasatinib: retrospective exposure-response analysis of a Phase III study